Risk factors associated with infections in pregnant women with systemic lupus erythematosus
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista da Associação Médica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000400536 |
Resumo: | SUMMARY OBJECTIVE: The aim of this study was to analyze the occurrence and risk factors associated with infections during pregnancy in patients with systemic lupus erythematosus. METHODS: This is a retrospective cohort study using the data of pregnant women who were followed up between 2011 and 2018 at a university hospital. RESULTS: The data of 221 pregnant women with systemic lupus erythematosus were analyzed. The incidence of infections was 22.6% (50/221), with the urinary tract being the most frequent site of infection (32/221, 14.5%) followed by the respiratory tract (15/221, 6.8%). The bivariate analysis showed that active disease, hematological systemic lupus erythematosus, reduced complement, and use of prednisone ≥5 and ≥10 mg increased the chance of infection during early pregnancy (p=0.05, p=0.04, p=0.003, p=0.008, and p=0.02, respectively), while disease activity and anti-DNA positivity increased it at the end of pregnancy (p=0.03 and p=0.04, respectively). Prednisone at a dose ≥5 mg increased the chance of infection in the beginning (p=0.01) and at the end of pregnancy (p=0.008). Multivariate analysis showed that increasing the dose of prednisone from 5 to 10 mg tripled the chance of developing infections in pregnant women with lupus (p=0.02). CONCLUSION: The study showed an increased chance of infections in pregnant women with systemic lupus erythematosus and it was associated with the use of prednisone. |
id |
AMB-1_27644b8be5bf0f703e1aab30ffc034ae |
---|---|
oai_identifier_str |
oai:scielo:S0104-42302022000400536 |
network_acronym_str |
AMB-1 |
network_name_str |
Revista da Associação Médica Brasileira (Online) |
repository_id_str |
|
spelling |
Risk factors associated with infections in pregnant women with systemic lupus erythematosusSystemic lupus erythematosusInfectionPregnancyRisk factorsSUMMARY OBJECTIVE: The aim of this study was to analyze the occurrence and risk factors associated with infections during pregnancy in patients with systemic lupus erythematosus. METHODS: This is a retrospective cohort study using the data of pregnant women who were followed up between 2011 and 2018 at a university hospital. RESULTS: The data of 221 pregnant women with systemic lupus erythematosus were analyzed. The incidence of infections was 22.6% (50/221), with the urinary tract being the most frequent site of infection (32/221, 14.5%) followed by the respiratory tract (15/221, 6.8%). The bivariate analysis showed that active disease, hematological systemic lupus erythematosus, reduced complement, and use of prednisone ≥5 and ≥10 mg increased the chance of infection during early pregnancy (p=0.05, p=0.04, p=0.003, p=0.008, and p=0.02, respectively), while disease activity and anti-DNA positivity increased it at the end of pregnancy (p=0.03 and p=0.04, respectively). Prednisone at a dose ≥5 mg increased the chance of infection in the beginning (p=0.01) and at the end of pregnancy (p=0.008). Multivariate analysis showed that increasing the dose of prednisone from 5 to 10 mg tripled the chance of developing infections in pregnant women with lupus (p=0.02). CONCLUSION: The study showed an increased chance of infections in pregnant women with systemic lupus erythematosus and it was associated with the use of prednisone.Associação Médica Brasileira2022-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000400536Revista da Associação Médica Brasileira v.68 n.4 2022reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.20220074info:eu-repo/semantics/openAccessValviesse,Daniele Maia de JesusMonteiro,Denise Leite MaiaJésus,Nilson Ramires deJésus,Guilherme Ribeiro Ramires deSantos,Flavia CunhaLacerda,Marcela IgnacchitiRodrigues,Nadia Cristina PereiraKlumb,Evandro Mendeseng2022-09-13T00:00:00Zoai:scielo:S0104-42302022000400536Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2022-09-13T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false |
dc.title.none.fl_str_mv |
Risk factors associated with infections in pregnant women with systemic lupus erythematosus |
title |
Risk factors associated with infections in pregnant women with systemic lupus erythematosus |
spellingShingle |
Risk factors associated with infections in pregnant women with systemic lupus erythematosus Valviesse,Daniele Maia de Jesus Systemic lupus erythematosus Infection Pregnancy Risk factors |
title_short |
Risk factors associated with infections in pregnant women with systemic lupus erythematosus |
title_full |
Risk factors associated with infections in pregnant women with systemic lupus erythematosus |
title_fullStr |
Risk factors associated with infections in pregnant women with systemic lupus erythematosus |
title_full_unstemmed |
Risk factors associated with infections in pregnant women with systemic lupus erythematosus |
title_sort |
Risk factors associated with infections in pregnant women with systemic lupus erythematosus |
author |
Valviesse,Daniele Maia de Jesus |
author_facet |
Valviesse,Daniele Maia de Jesus Monteiro,Denise Leite Maia Jésus,Nilson Ramires de Jésus,Guilherme Ribeiro Ramires de Santos,Flavia Cunha Lacerda,Marcela Ignacchiti Rodrigues,Nadia Cristina Pereira Klumb,Evandro Mendes |
author_role |
author |
author2 |
Monteiro,Denise Leite Maia Jésus,Nilson Ramires de Jésus,Guilherme Ribeiro Ramires de Santos,Flavia Cunha Lacerda,Marcela Ignacchiti Rodrigues,Nadia Cristina Pereira Klumb,Evandro Mendes |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Valviesse,Daniele Maia de Jesus Monteiro,Denise Leite Maia Jésus,Nilson Ramires de Jésus,Guilherme Ribeiro Ramires de Santos,Flavia Cunha Lacerda,Marcela Ignacchiti Rodrigues,Nadia Cristina Pereira Klumb,Evandro Mendes |
dc.subject.por.fl_str_mv |
Systemic lupus erythematosus Infection Pregnancy Risk factors |
topic |
Systemic lupus erythematosus Infection Pregnancy Risk factors |
description |
SUMMARY OBJECTIVE: The aim of this study was to analyze the occurrence and risk factors associated with infections during pregnancy in patients with systemic lupus erythematosus. METHODS: This is a retrospective cohort study using the data of pregnant women who were followed up between 2011 and 2018 at a university hospital. RESULTS: The data of 221 pregnant women with systemic lupus erythematosus were analyzed. The incidence of infections was 22.6% (50/221), with the urinary tract being the most frequent site of infection (32/221, 14.5%) followed by the respiratory tract (15/221, 6.8%). The bivariate analysis showed that active disease, hematological systemic lupus erythematosus, reduced complement, and use of prednisone ≥5 and ≥10 mg increased the chance of infection during early pregnancy (p=0.05, p=0.04, p=0.003, p=0.008, and p=0.02, respectively), while disease activity and anti-DNA positivity increased it at the end of pregnancy (p=0.03 and p=0.04, respectively). Prednisone at a dose ≥5 mg increased the chance of infection in the beginning (p=0.01) and at the end of pregnancy (p=0.008). Multivariate analysis showed that increasing the dose of prednisone from 5 to 10 mg tripled the chance of developing infections in pregnant women with lupus (p=0.02). CONCLUSION: The study showed an increased chance of infections in pregnant women with systemic lupus erythematosus and it was associated with the use of prednisone. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-04-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000400536 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000400536 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1806-9282.20220074 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Médica Brasileira |
publisher.none.fl_str_mv |
Associação Médica Brasileira |
dc.source.none.fl_str_mv |
Revista da Associação Médica Brasileira v.68 n.4 2022 reponame:Revista da Associação Médica Brasileira (Online) instname:Associação Médica Brasileira (AMB) instacron:AMB |
instname_str |
Associação Médica Brasileira (AMB) |
instacron_str |
AMB |
institution |
AMB |
reponame_str |
Revista da Associação Médica Brasileira (Online) |
collection |
Revista da Associação Médica Brasileira (Online) |
repository.name.fl_str_mv |
Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB) |
repository.mail.fl_str_mv |
||ramb@amb.org.br |
_version_ |
1754212837425676288 |